SE9603668D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
SE9603668D0
SE9603668D0 SE9603668A SE9603668A SE9603668D0 SE 9603668 D0 SE9603668 D0 SE 9603668D0 SE 9603668 A SE9603668 A SE 9603668A SE 9603668 A SE9603668 A SE 9603668A SE 9603668 D0 SE9603668 D0 SE 9603668D0
Authority
SE
Sweden
Prior art keywords
undesirable
compositions
pharmaceutical compositions
hmg
sustained release
Prior art date
Application number
SE9603668A
Other languages
Swedish (sv)
Inventor
Bertil Abrahamsson
Gunnar Fager
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603668A priority Critical patent/SE9603668D0/en
Publication of SE9603668D0 publication Critical patent/SE9603668D0/en
Priority to PCT/SE1997/001605 priority patent/WO1998015290A1/en
Priority to AU45781/97A priority patent/AU4578197A/en

Links

Abstract

The present invention relates to pharmaceutical compositions for sustained release of HMG-CoA reductase inhibitors, in particular fluvastatin. The said compositions are useful for the treatment of hypercholesterolemia, and have the further advantages of (i) decreasing the incidence of undesirable gastro-intestinal side-effects, and (ii) avoiding undesirable increases of serum transaminase levels. Furthermore, undesirable up-regulation of HMG-CoA reductase levels is significantly reduced by administration of the said sustained release compositions.
SE9603668A 1996-10-08 1996-10-08 Pharmaceutical compositions SE9603668D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9603668A SE9603668D0 (en) 1996-10-08 1996-10-08 Pharmaceutical compositions
PCT/SE1997/001605 WO1998015290A1 (en) 1996-10-08 1997-09-24 PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-CoA REDUCTASE INHIBITORS, IN PARTICULAR FLUVASTATIN
AU45781/97A AU4578197A (en) 1996-10-08 1997-09-24 Pharmaceutical compositions comprising hmg-coa reductase inhibitors, in particular fluvastatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603668A SE9603668D0 (en) 1996-10-08 1996-10-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE9603668D0 true SE9603668D0 (en) 1996-10-08

Family

ID=20404166

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603668A SE9603668D0 (en) 1996-10-08 1996-10-08 Pharmaceutical compositions

Country Status (3)

Country Link
AU (1) AU4578197A (en)
SE (1) SE9603668D0 (en)
WO (1) WO1998015290A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
WO2007016757A1 (en) * 2005-08-05 2007-02-15 Orbus Pharma Inc. Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor
AU2007355452B2 (en) * 2007-06-25 2011-12-15 Pharmathen S.A. Improved pharmaceutical formulation containing an HMG-CoA reductase inhibitor and method for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2045428A1 (en) * 1990-06-26 1991-12-27 Alfred W. Alberts Method for enhancing the lowering of plasma cholesterol levels
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them

Also Published As

Publication number Publication date
AU4578197A (en) 1998-05-05
WO1998015290A1 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
HUP0004318A2 (en) Pharmaceutical composition comprising atorvastatin and an antihypertensive agent
RU2008111710A (en) COMPOSITION FOR EMERGENCY DELIVERY OF MEDICINES
DE69720778D1 (en) MEDICINES FOR DELAYED RELEASE OF HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN
WO1999006035A3 (en) COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT
WO1998040375A3 (en) COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS
GEP20063956B (en) Cell adhesion inhibitors
MY123993A (en) Therapeutic combinations
WO2002024194A3 (en) Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
CA2297764A1 (en) Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia
ATE283050T1 (en) DELAYED RELEASE COMPOSITIONS FOR THE TREATMENT OF HYPERLIPIDEMIA
BR9714364A (en) Apo b / mtp secretion inhibiting amides
MY138289A (en) Pharmaceutical compositions
NO20016007L (en) Recombinant anti-CD40 antibody and uses thereof
BG105559A (en) STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
AP1745A (en) Pharmaceutical compositions of amlodipine and atorvastatin.
ATE260658T1 (en) PHARMACEUTICAL PREPARATIONS FOR REDUCING RESPIRATORY DEPRESSION
DE69725860D1 (en) PLAN FOR ADMINISTRATION OF H +, K + -ATPase INHIBITORS
DK1053240T3 (en) Glucocorticoid-selective anti-inflammatory agents
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
DE69720996D1 (en) NEW PHARMACEUTICAL COMPOSITIONS OF STEROID NITRATE ESTER FOR USE AS AN INFLAMMATORY INHIBITOR
SE9603668D0 (en) Pharmaceutical compositions
MY118381A (en) Statin-carboxyalkylether combinations
ATE342261T1 (en) PYRAND DERIVATIVES AS INHIBITORS OF ACE AND NEP
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
EP1466601A3 (en) Prevention of migraine recurrence